These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 20696878

  • 1. Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model.
    Tré-Hardy M, Nagant C, El Manssouri N, Vanderbist F, Traore H, Vaneechoutte M, Dehaye JP.
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4409-15. PubMed ID: 20696878
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M, Traore H, El Manssouri N, Vanderbist F, Vaneechoutte M, Devleeschouwer MJ.
    Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M, Morosini MI, Köksal E, Oliver A, Ekkelenkamp M, Cantón R.
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M, Vanderbist F, Traore H, Devleeschouwer MJ.
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [Abstract] [Full Text] [Related]

  • 7. Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells.
    Moreau-Marquis S, Coutermarsh B, Stanton BA.
    J Antimicrob Chemother; 2015 Jan; 70(1):160-6. PubMed ID: 25213272
    [Abstract] [Full Text] [Related]

  • 8. The ionophore oxyclozanide enhances tobramycin killing of Pseudomonas aeruginosa biofilms by permeabilizing cells and depolarizing the membrane potential.
    Maiden MM, Zachos MP, Waters CM.
    J Antimicrob Chemother; 2019 Apr 01; 74(4):894-906. PubMed ID: 30624737
    [Abstract] [Full Text] [Related]

  • 9. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.
    Yu Q, Griffin EF, Moreau-Marquis S, Schwartzman JD, Stanton BA, O'Toole GA.
    J Antimicrob Chemother; 2012 Nov 01; 67(11):2673-81. PubMed ID: 22843834
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
    Koeva M, Gutu AD, Hebert W, Wager JD, Yonker LM, O'Toole GA, Ausubel FM, Moskowitz SM, Joseph-McCarthy D.
    Antimicrob Agents Chemother; 2017 Dec 01; 61(12):. PubMed ID: 28923873
    [Abstract] [Full Text] [Related]

  • 12. In Vitro Evaluation of Biofilm Dispersal as a Therapeutic Strategy To Restore Antimicrobial Efficacy.
    Roizman D, Vidaillac C, Givskov M, Yang L.
    Antimicrob Agents Chemother; 2017 Oct 01; 61(10):. PubMed ID: 28760898
    [Abstract] [Full Text] [Related]

  • 13. Triclosan Is an Aminoglycoside Adjuvant for Eradication of Pseudomonas aeruginosa Biofilms.
    Maiden MM, Hunt AMA, Zachos MP, Gibson JA, Hurwitz ME, Mulks MH, Waters CM.
    Antimicrob Agents Chemother; 2018 Jun 01; 62(6):. PubMed ID: 29661867
    [Abstract] [Full Text] [Related]

  • 14. Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm.
    Lutz L, Pereira DC, Paiva RM, Zavascki AP, Barth AL.
    BMC Microbiol; 2012 Sep 08; 12():196. PubMed ID: 22958421
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Novel combination proliposomes containing tobramycin and clarithromycin effective against Pseudomonas aeruginosa biofilms.
    Ye T, Sun S, Sugianto TD, Tang P, Parumasivam T, Chang YK, Astudillo A, Wang S, Chan HK.
    Int J Pharm; 2018 Dec 01; 552(1-2):130-138. PubMed ID: 30267753
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice.
    Kirby BD, Al Ahmar R, Withers TR, Valentine ME, Valentovic M, Long TE, Gaskins JR, Yu HD.
    Antimicrob Agents Chemother; 2019 Jul 01; 63(7):. PubMed ID: 31010865
    [Abstract] [Full Text] [Related]

  • 20. Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections.
    Rojo-Molinero E, Macià MD, Rubio R, Moyà B, Cabot G, López-Causapé C, Pérez JL, Cantón R, Oliver A.
    Antimicrob Agents Chemother; 2016 May 01; 60(5):2912-22. PubMed ID: 26926631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.